advancing innovation to save lives

GHTC's statement on the President's FY19 budget

GHTC released a statement in response to the President's fiscal year (FY) 2019 budget proposal, expressing concern about proposed cuts to critical government programs that advance innovation to improve the health of millions of people in need around the world, including Americans.
Learn More

The first step

GHTC released a new two-minute video taking viewers on a journey to discover how sustained investments in global health R&D can unlock health and opportunity for people around the world.
View

Member Spotlight: Johns Hopkins Center for Health Security

The Johns Hopkins Center for Health Security is an independent nonprofit organization that works to protect people's health from the consequences of epidemics and disasters and to ensure that communities are resilient to major challenges.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more
PATH/Heng Chivoan
RAPS looks at regulatory findings in GHTC Saving Lives report

Regulatory Affairs Professionals Society (RAPS) explores the US Food and Drug Administration's (FDA) involvement in global health R&D, citing findings from GHTC's report Saving lives and creating impact, which notes that the FDA's approval of products intended for non-US markets can help facilitate product approval and introduction in low- and middle-income countries.

View
PATH/Patrick McKern
Global Health Matters cites GHTC report on US R&D impact

In its May/June issue, the Fogarty International Center Global Health Matters newsletter cites GHTC's report Saving lives and creating impact, which found that the US government contributed to 24 of the 45 new global health products developed between 2000 and 2010.

View
View All News & Events

Community Event

PATH/Gabe Bienczycki
Devex World 2018
Devex, Cargill, Pfizer, Johnson & Johnson, RTI
Learn More

Community Event

InterAction Forum 2018
InterAction
Learn More
View All Events
Pan American Health Organization
What to watch at WHA 71

The 71st session of the World Health Assembly will see a number of debates that could impact global health R&D. Here is is what you need to know.

Read More
Neil Palmer/CIAT
Preparing the ground in the Brazilian Amazon for a new antimalarial to reduce relapse

Tackling malaria in the Brazilian Amazon has proved challenging. But furtunetly, a solution could be in sight.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide